236 related articles for article (PubMed ID: 18006927)
21. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.
Suzuki H; Morris JS; Li Y; Doll MA; Hein DW; Liu J; Jiao L; Hassan MM; Day RS; Bondy ML; Abbruzzese JL; Li D
Carcinogenesis; 2008 Jun; 29(6):1184-91. PubMed ID: 18499698
[TBL] [Abstract][Full Text] [Related]
22. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
[TBL] [Abstract][Full Text] [Related]
23. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M
BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288
[TBL] [Abstract][Full Text] [Related]
24. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
[TBL] [Abstract][Full Text] [Related]
25. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M
Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677
[TBL] [Abstract][Full Text] [Related]
26. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
[TBL] [Abstract][Full Text] [Related]
27. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
Hou ZD; Xiao ZY; Gong Y; Zhang YP; Zeng QY
BMC Pharmacol Toxicol; 2014 Nov; 15():64. PubMed ID: 25413361
[TBL] [Abstract][Full Text] [Related]
28. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster.
Hein DW; Doll MA; Xiao GH; Feng Y
Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
30. The association between N-acetyltransferase 2 gene polymorphisms and pancreatic cancer.
Ayaz L; Ercan B; Dirlik M; Atik U; Tamer L
Cell Biochem Funct; 2008 Apr; 26(3):329-33. PubMed ID: 18027363
[TBL] [Abstract][Full Text] [Related]
31. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.
Nöthlings U; Yamamoto JF; Wilkens LR; Murphy SP; Park SY; Henderson BE; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2098-106. PubMed ID: 19549810
[TBL] [Abstract][Full Text] [Related]
32. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.
Gong C; Hu X; Gao Y; Cao Y; Gao F; Mo Z
Med Oncol; 2011 Mar; 28(1):365-76. PubMed ID: 20099048
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.
Hernández-González O; Ortiz-Zamudio JJ; Rodríguez-Pinal CJ; Alvarado-Morales I; Martínez-Jiménez VDC; Salazar-González RA; Correa-González LC; Gómez R; Portales-Pérez DP; Milán-Segovia RDC
Leuk Lymphoma; 2018 Aug; 59(8):1968-1975. PubMed ID: 29214875
[TBL] [Abstract][Full Text] [Related]
35. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
[TBL] [Abstract][Full Text] [Related]
36. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
37. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
38. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
[TBL] [Abstract][Full Text] [Related]
39. Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes.
Salazar-González RA; Doll MA; Hein DW
Sci Rep; 2020 May; 10(1):7566. PubMed ID: 32372066
[TBL] [Abstract][Full Text] [Related]
40. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
